Value of high-sensitivity C-reactive protein in low risk chest pain observation unit patients

Deborah B. Diercks, J. Douglas Kirk, Seif Naser, Samuel Turnipseed, Ezra A. Amsterdam

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: High-sensitivity C-reactive protein (hs-CRP) rises with cardiac injury/ischemia. We evaluated its efficacy in aiding in the identification of an acute coronary syndrome (ACS) in patients (pts) admitted to the chest pain unit (CPU) for possible ACS. Methods: Retrospective study of all patients admitted to the CPU with chest pain who underwent hs-CRP testing as part of their CPU evaluation from January 2004 to October 2008. Patients were low risk for ACS (compatible symptoms, nondiagnostic initial ECG, and negative cTnI). ACS was diagnosed by positive functional study, cardiac catheterization, or cardiac event during 30-day follow-up. Positive hs-CRP was defined based on local laboratorylevels (>1.0 mg/l or >3.0 mg/l), and population-based and prior study values >2.0 mg/l. Chi-square analysis was performed, and odds ratios (OR) are presented. Multivariate analysis was done to determine whether hs-CRP was independently associated with the diagnosis of ACS. Cardiac risk factors, demographics, and iagnosis of ACS were included in the model. Medians with IQR are presented for continuous data. Ninety-five percent confidence intervals are presented where applicable. Results: A total of 958 patients had hs-CRP testing as part of their CPEU evaluation. Excluded from the analysis were 39 patients lost to follow-up. The final cohort comprised 478 (52%) women and 441 (48%) men with a median age of 56 (IQR 48-64). ACS was diagnosed in 128 (13.4%). The median cohort hs-CRP value was 2.2 mg/l (IQR 0.7, 5.8) and 2.3 mg/l (IQR 0.6, 5.9) in those with and without ACS, respectively. In the multivariate analysis hs-CRP was not independently associated with the diagnosis of ACS (0.99; 95% CI 0.98 - 1.01). Conclusion: In large patient cohort managed in a single-center CPU, measurement of hs-CRP did not enhance the diagnostic accuracy for ACS. Routine hs-CRP as a diagnostic tool should not be recommended in the CPU setting.

Original languageEnglish (US)
Article number37
JournalInternational Journal of Emergency Medicine
Volume4
Issue number1
DOIs
StatePublished - Dec 2011

Fingerprint

Acute Coronary Syndrome
Chest Pain
C-Reactive Protein
Observation
Multivariate Analysis
Lost to Follow-Up
Pain Measurement
Cardiac Catheterization
Electrocardiography
Ischemia
Retrospective Studies
Odds Ratio
Demography
Confidence Intervals
Wounds and Injuries

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Value of high-sensitivity C-reactive protein in low risk chest pain observation unit patients. / Diercks, Deborah B.; Kirk, J. Douglas; Naser, Seif; Turnipseed, Samuel; Amsterdam, Ezra A.

In: International Journal of Emergency Medicine, Vol. 4, No. 1, 37, 12.2011.

Research output: Contribution to journalArticle

Diercks, Deborah B. ; Kirk, J. Douglas ; Naser, Seif ; Turnipseed, Samuel ; Amsterdam, Ezra A. / Value of high-sensitivity C-reactive protein in low risk chest pain observation unit patients. In: International Journal of Emergency Medicine. 2011 ; Vol. 4, No. 1.
@article{5d666f6d220344bbb9facbd2ea39d637,
title = "Value of high-sensitivity C-reactive protein in low risk chest pain observation unit patients",
abstract = "Objective: High-sensitivity C-reactive protein (hs-CRP) rises with cardiac injury/ischemia. We evaluated its efficacy in aiding in the identification of an acute coronary syndrome (ACS) in patients (pts) admitted to the chest pain unit (CPU) for possible ACS. Methods: Retrospective study of all patients admitted to the CPU with chest pain who underwent hs-CRP testing as part of their CPU evaluation from January 2004 to October 2008. Patients were low risk for ACS (compatible symptoms, nondiagnostic initial ECG, and negative cTnI). ACS was diagnosed by positive functional study, cardiac catheterization, or cardiac event during 30-day follow-up. Positive hs-CRP was defined based on local laboratorylevels (>1.0 mg/l or >3.0 mg/l), and population-based and prior study values >2.0 mg/l. Chi-square analysis was performed, and odds ratios (OR) are presented. Multivariate analysis was done to determine whether hs-CRP was independently associated with the diagnosis of ACS. Cardiac risk factors, demographics, and iagnosis of ACS were included in the model. Medians with IQR are presented for continuous data. Ninety-five percent confidence intervals are presented where applicable. Results: A total of 958 patients had hs-CRP testing as part of their CPEU evaluation. Excluded from the analysis were 39 patients lost to follow-up. The final cohort comprised 478 (52{\%}) women and 441 (48{\%}) men with a median age of 56 (IQR 48-64). ACS was diagnosed in 128 (13.4{\%}). The median cohort hs-CRP value was 2.2 mg/l (IQR 0.7, 5.8) and 2.3 mg/l (IQR 0.6, 5.9) in those with and without ACS, respectively. In the multivariate analysis hs-CRP was not independently associated with the diagnosis of ACS (0.99; 95{\%} CI 0.98 - 1.01). Conclusion: In large patient cohort managed in a single-center CPU, measurement of hs-CRP did not enhance the diagnostic accuracy for ACS. Routine hs-CRP as a diagnostic tool should not be recommended in the CPU setting.",
author = "Diercks, {Deborah B.} and Kirk, {J. Douglas} and Seif Naser and Samuel Turnipseed and Amsterdam, {Ezra A.}",
year = "2011",
month = "12",
doi = "10.1186/1865-1380-4-37",
language = "English (US)",
volume = "4",
journal = "International Journal of Emergency Medicine",
issn = "1865-1372",
publisher = "Springer London",
number = "1",

}

TY - JOUR

T1 - Value of high-sensitivity C-reactive protein in low risk chest pain observation unit patients

AU - Diercks, Deborah B.

AU - Kirk, J. Douglas

AU - Naser, Seif

AU - Turnipseed, Samuel

AU - Amsterdam, Ezra A.

PY - 2011/12

Y1 - 2011/12

N2 - Objective: High-sensitivity C-reactive protein (hs-CRP) rises with cardiac injury/ischemia. We evaluated its efficacy in aiding in the identification of an acute coronary syndrome (ACS) in patients (pts) admitted to the chest pain unit (CPU) for possible ACS. Methods: Retrospective study of all patients admitted to the CPU with chest pain who underwent hs-CRP testing as part of their CPU evaluation from January 2004 to October 2008. Patients were low risk for ACS (compatible symptoms, nondiagnostic initial ECG, and negative cTnI). ACS was diagnosed by positive functional study, cardiac catheterization, or cardiac event during 30-day follow-up. Positive hs-CRP was defined based on local laboratorylevels (>1.0 mg/l or >3.0 mg/l), and population-based and prior study values >2.0 mg/l. Chi-square analysis was performed, and odds ratios (OR) are presented. Multivariate analysis was done to determine whether hs-CRP was independently associated with the diagnosis of ACS. Cardiac risk factors, demographics, and iagnosis of ACS were included in the model. Medians with IQR are presented for continuous data. Ninety-five percent confidence intervals are presented where applicable. Results: A total of 958 patients had hs-CRP testing as part of their CPEU evaluation. Excluded from the analysis were 39 patients lost to follow-up. The final cohort comprised 478 (52%) women and 441 (48%) men with a median age of 56 (IQR 48-64). ACS was diagnosed in 128 (13.4%). The median cohort hs-CRP value was 2.2 mg/l (IQR 0.7, 5.8) and 2.3 mg/l (IQR 0.6, 5.9) in those with and without ACS, respectively. In the multivariate analysis hs-CRP was not independently associated with the diagnosis of ACS (0.99; 95% CI 0.98 - 1.01). Conclusion: In large patient cohort managed in a single-center CPU, measurement of hs-CRP did not enhance the diagnostic accuracy for ACS. Routine hs-CRP as a diagnostic tool should not be recommended in the CPU setting.

AB - Objective: High-sensitivity C-reactive protein (hs-CRP) rises with cardiac injury/ischemia. We evaluated its efficacy in aiding in the identification of an acute coronary syndrome (ACS) in patients (pts) admitted to the chest pain unit (CPU) for possible ACS. Methods: Retrospective study of all patients admitted to the CPU with chest pain who underwent hs-CRP testing as part of their CPU evaluation from January 2004 to October 2008. Patients were low risk for ACS (compatible symptoms, nondiagnostic initial ECG, and negative cTnI). ACS was diagnosed by positive functional study, cardiac catheterization, or cardiac event during 30-day follow-up. Positive hs-CRP was defined based on local laboratorylevels (>1.0 mg/l or >3.0 mg/l), and population-based and prior study values >2.0 mg/l. Chi-square analysis was performed, and odds ratios (OR) are presented. Multivariate analysis was done to determine whether hs-CRP was independently associated with the diagnosis of ACS. Cardiac risk factors, demographics, and iagnosis of ACS were included in the model. Medians with IQR are presented for continuous data. Ninety-five percent confidence intervals are presented where applicable. Results: A total of 958 patients had hs-CRP testing as part of their CPEU evaluation. Excluded from the analysis were 39 patients lost to follow-up. The final cohort comprised 478 (52%) women and 441 (48%) men with a median age of 56 (IQR 48-64). ACS was diagnosed in 128 (13.4%). The median cohort hs-CRP value was 2.2 mg/l (IQR 0.7, 5.8) and 2.3 mg/l (IQR 0.6, 5.9) in those with and without ACS, respectively. In the multivariate analysis hs-CRP was not independently associated with the diagnosis of ACS (0.99; 95% CI 0.98 - 1.01). Conclusion: In large patient cohort managed in a single-center CPU, measurement of hs-CRP did not enhance the diagnostic accuracy for ACS. Routine hs-CRP as a diagnostic tool should not be recommended in the CPU setting.

UR - http://www.scopus.com/inward/record.url?scp=84857671286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857671286&partnerID=8YFLogxK

U2 - 10.1186/1865-1380-4-37

DO - 10.1186/1865-1380-4-37

M3 - Article

VL - 4

JO - International Journal of Emergency Medicine

JF - International Journal of Emergency Medicine

SN - 1865-1372

IS - 1

M1 - 37

ER -